
Ovaplus L 2.5mg Tablet
Marketer
Liveon Healthcare Pvt Ltd
Salt Composition
Letrozole (2.5mg)
Overview Ovaplus L 2.5mg Tablet
Post-menopausal women with breast cancer may find relief with Ovaplus L 2.5mg tablets. This medication can be a standalone treatment or used alongside surgery or radiotherapy. In advanced cases, it helps prevent cancer spread. Ovaplus L 2.5mg can be administered with or without food, always following your physician's prescribed dosage and duration for optimal results. Dosage frequency varies based on individual needs and will be determined by your doctor to manage your symptoms effectively. Continuous use as directed is crucial. Common side effects, such as hot flushes, tiredness, excessive perspiration, and elevated cholesterol, may occur. Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you are currently taking, as interactions may affect efficacy. Disclose pregnancy or breastfeeding status to your doctor. Pre- and ongoing monitoring, potentially including blood tests for vitamin D levels and bone density, may be conducted.
Primary Ingredients of Ovaplus L 2.5mg Tablet
No text provided to rephrase.
Uses of Ovaplus L 2.5mg Tablet
Managing breast cancer
Major Benefits of Ovaplus L 2.5mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ovaplus L 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Ovaplus L 2.5mg Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Ovaplus L 2.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Ovaplus L 2.5mg Tablets. Ingest the tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Ovaplus L 2.5mg Tablet works:
Estrogen production is reduced by Ovaplus L 2.5mg Tablets, an aromatase inhibitor. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ovaplus L 2.5mg Tablet and alcohol consumption.
PregnancyUNSAFE
Administering Ovaplus L 2.5mg tablets during pregnancy carries a substantial risk. Pregnant individuals should consult their physician; research involving both animals and pregnant women reveals considerable adverse effects on fetal development.
Breast feedingUNSAFE
Lactation and the use of Ovaplus L 2.5mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking Ovaplus L 2.5mg Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The 2.5mg Ovaplus L Tablet is considered safe for individuals with kidney impairment; dosage modification isn't typically necessary. Nevertheless, data regarding its use in patients experiencing end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Ovaplus L 2.5mg Tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ovaplus L 2.5mg Tablet :
Should you forget to take your Ovaplus L 2.5mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ovaplus L 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
